The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zorian E.V.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Rabinovich S.A.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

The effectiveness and safety of nonsteroidal anti-inflammatory drugs

Authors:

Zorian E.V., Rabinovich S.A.

More about the authors

Journal: Russian Journal of Stomatology. 2016;9(3): 42‑48

DOI: 10.17116/rosstomat20169342-48

Views: 5388

Downloaded: 94

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Zorian EV, Rabinovich SA. The effectiveness and safety of nonsteroidal anti-inflammatory drugs. Russian Journal of Stomatology. 2016;9(3):42‑48. (In Russ.)
https://doi.org/10.17116/rosstomat20169342-48

 
МСФ на ЯМ
Close metadata
Recommended articles:
On the issue of choosing anesthesia methods: a comparison of gene­ral medi­cine and clinical dentistry. Stomatology. 2025;(1):76-80

This article was designed to analyze the specific features of the action of various nonsteroidal anti-inflammatory drugs influencing the effectiveness and the safety of the treatment.

Keywords:

nonsteroidal anti-inflammatory drugs (NSAIDs)
NSAID inhibiting cyclooxygenases COX-1 and COX-2
NSAID preferentially or selectively inhibiting C-2
specific features of NSAID action
adverse reactions

Authors:

Zorian E.V.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

Rabinovich S.A.

Moskovskiĭ gosudarstvennyĭ mediko-stomatologicheskiĭ universitet

List of references:

  1. Akarachkova E.S., Zaitseva I.A. Osnovnye printsipy terapii: effektivnost', bezopasnost', individual'nyi podkhod. Consillium medicum. 2012;2(14):116-119.
  2. Bazikyan E.A., Ignatovich V.V. Otsenka effektivnosti ketorola i naiza v klinicheskoi praktike khirurgicheskoi stomatologii. Stomatologiya. 2005;3:49-50.
  3. Barer G.M., Zoryan E.V., red. Ratsional'naya farmakoterpiya v stomatologii. Rukovodstvo dlya praktikuyushchikh vrachei. M.: Litterra; 2006.
  4. Barer G.M. Terapevticheskaya stomatologiya. Chast' 2. Bolezni parodonta: uchebnik. M.: Geotar-Media; 2008.
  5. Bezrukov V.M., Grigor'yants L.A., Shafranskii i dr. Opyt ispol'zovaniya preparata ketanov pri odnovremennom ispol'zovanii s mestnymi anestetikami i sredstvami dlya vnutrivennoi anestezii. Stomatologiya. 2003;4:67-68.
  6. Veber V.R., Moroz B.T. Klinicheskaya farmakologiya dlya stomatologov: Uchebnoe posobie. SPb.: Izd-vo «Chelovek»; 2003.
  7. Veber V.R. Klinicheskaya farmakologiya. Uchebnoe posobie dlya studentov i vrachei. SPb.: izd-vo «Chelovek»; 2004.
  8. Evseev M.A. Nesteroidnye protivovospalitel'nye preparaty i pishchevaritel'nyi trakt. M.: OOO «Kompaniya Borges»; 2008.
  9. Evseev M.A., Kruglyanskii Yu.M. NPVS-indutsirovannaya enteropatiya: osobennosti epidemiologii, patogeneza i klinicheskogo techeniya. Russkii meditsinskii zhurnal. 2008;16(7):523-528.
  10. Zoryan E.V.. Rabinovich S.A. Osnovnye napravleniya profilaktiki i ustraneniya boli v ambulatornoi stomatologii. Rossiiskaya stomatologiya. 2006;1(1):22-28.
  11. Zoryan E.V., Rabinovich S.A. Osnovnye napravleniya profilaktiki i ustraneniya boli v ambulatornoi stomatologii. Rossiiskaya stomatologiya. 2008;1(1):22-28.
  12. Karateev A.E., Yakhno N.N., Lazebnik L.B., Kukushkin M.L., Drozdov V.N.. Isakov V.A., Nasonov E.L. Primenenie nesteroidnykh protivovospalitel'nykh preparatov: klinicheskie rekomendatsii. M.: IMA-PRESS; 2009.
  13. Karateev A.E. Tselekoksib, etorikoksib, meloksikam i nimesulid: dostoinstva i nedostatki. Effektivnaya farmakoterapiya. Revmatologiya. Travmatologiya. Ortopediya. 2011;1:28-37.
  14. Karateev A.E. Nimesulid vo vtorom desyatiletii XXI v Consillium medicum. 2012;2(14):104-110.
  15. Nasonov E.L. Nesteroidnye protivovospalitel'nye preparaty (perspektivy primeneniya v meditsine). M.: Izd-vo «Anko»; 2000.
  16. Ovechkin A.M. Nesteroidnye protivovospalitel'nye sredstva v anesteziologii i khirurgii. Regionarnaya anesteziya i lechenie ostroi boli. 2009;3(2):5-14.
  17. Osipova N.A. Preventivnoe lechenie snimaet ostrotu bolevogo sindroma. 5-i Rossiiskii natsional'nyi kongress «Chelovek i lekarstvo». 1998;34:58.
  18. Rabinovich S.A., Zoryan E.V., Dobrodeev A.S. Sedatsiya v stomatologii. M.: Liga; 2013.
  19. Revmatologiya: klinicheskie rekomendatsii. Pod red. Nasonova E.L. M.: GEOTAR-Media; 2010.
  20. Sechko O.N. Ispol'zovanie sovremennykh protivovospalitel'nykh preparatov v kompleksnom lechenii parodontita: Avtoref. diss. ... kand. med. nauk. M.; 1998.
  21. Sidel'nikov P.V., Chub V.V. Puti povysheniya kachestva obezbolivaniya pri provedenii kostno-plasticheskikh operatsii s dental'noi implantatsiei. Sovremennaya stomatologiya. 2008;2:29-32.
  22. Sokhov S.T., Aksamit L.A., Vikha G.V., Vorob'eva E.I., Tsvetkova A.A. Primenenie nesteroidnykh protivovospalitel'nykh sredstv dlya lecheniya stomatologicheskikh zabolevanii. M.; 2011.
  23. Yakhno N.N., Kukushkin M.L. Sovremennoi sostoyanie problemy boli v Rossii i perspektivy razvitiya. Materialy konferentsii Bolevye sindromy v oblasti golovy, litsa i polosti rta. Smolensk, 9-10 sentyabrya 2010. Smolensk; 2010:4-6.
  24. Attar S, Bowles WR, Baisden MK, Hodges JS, McClanahan SB. Evaluation analgesia and endodontic treatment for post-operative endodontic pain. J Endod. 2008;34(6):652-655.
  25. Aoki T, Yamaguchi H, Naito H et al. Premedication with cyclooxygenase-2 inhibitor meloxicam reduced postoperative pain in patients after oral surgery. Int J Oral Maxillofac Surg. 2006;35:613-616.
  26. Bocanegra M, Seijas A, Gonzalez Yibirin M. Effectiveness and tolerability of once-daily nimesulide versus ibuprofen in pain management after surgical extraction of an impacted third molar: a 24-hour, double-blind, randomized, double-dummy, parallel-group study. Curr Ther Res. 2005;66:172-180.
  27. Bucley M, Brogden R Ketorolac. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential. Drugs. 1990;39:86-109.
  28. Costa FWG, Soares ECS, Esses DFS, deB Silva PG, Bezerra TP, Scarparo HC, Ribeiro TR, Fonteles CSR. A split-mouth, randomized, triple-blind, placebo-controlled study to analyze the pre-emptive effect of etoricoxib 120 mg on inflammatory events following removal of unerupted mandibular third molars. Int J Oral Maxillofac Surg. 2015;44:1166-1174.
  29. Crofford LJ, Lipsky PE, Brooks P et al, Basic biology and clinical application of specific cyclooxigenase-2 inhibitors. Arthr Rheum. 2000;43:4-13.
  30. Daniels SE, Bandy DP, Christensen SE, Boice J, Losada MC, Liu H et al. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model. Clin J Pain. 2011;27:1-8.
  31. De Brum-Fernandes AJ, Laporte S, Heroux M et al. Expression of prostaglandin endoperoxide synthase-1 and prostaglandin endoperoxide synthase-2 in human osteoblasts. Biochem Biophys Res Commun. 1994;198:955-960.
  32. De Oliveira GS Jr, Agarwal D, Benzon HT. Perioperative single dose ketorolac to prevent postoperative pain: a meta-analysis of randomized trials. Anesth Analg. 2012;114(2):424-433.
  33. Dias-Gonzales F Gonzales-Alvaro I, Campanero MR et al. Prevention of in vitro neutrophil-endothelial attachment through sheding of L-selectin by nonsteroidal antiinflammatory drugs. J Clin Invest. 1995;95:1756-1765.
  34. El Attar TMA, Sin HS, Tira DE. Arachidonic acid metabolism in inflamed gingiva and its inhibition by anti-inflammatory drugs. J Periodontol. 1984;55:536-539.
  35. Fitzgarald GA, Partono C. The coxibs, selective inhibitors of cyclooxigenase-2. N Engl J Med. 2001;345:433-442.
  36. Gales BJ, Gales MA. Death associated with inappropriate ketorolac dosing. Ann Pharmacother. 1995;29:1299.
  37. Geise J, McDonald JJ, Hauser SD et al. A single amino acid difference between cyclooxygenase-1 (COX-1) and -2 (COX-2) reverses the selectivity of COX-2 specific inhibitors. J Biol Chem. 1996;271:15810-15814.
  38. Jeske AH. COX-2 inhibitors and dental pain control. J Gt Host Dent Soc. 1999;71(4):39-40.
  39. Kissin I. Preemptive analgesia. Anesthesiology. 2000;93:1138-1143.
  40. Kurumbail RG, Stevens AM, Gierse JK et al. Structural basis for selective inhibition of cycloxygenase-2 by anti-inflammatory agents. Nature. 1996;384:644-648.
  41. Lai KSW, Chu KM et al Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Am J Med. 2005;118:1271-1278.
  42. Langman MJ. Epidemiology of nonsteroidal anti-inflammatory drug damage to stomach and duodenum. Ital J Gastroenterol Hepatol. 1999;33(Suppl.1):2-5.
  43. McCormack K. The spinal actions of nonsteroidal anti-inflammatory drugs and the dissociation between their anti-inflammatory and analgesic effects. Drugs. 1994;47(Suppl.5):28-45.
  44. McDaid C, Maund E, Rice S et al. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs (NSAIDs) for the reduction of morphine-related side effects after major surgery: a systematic review. Health Technol Assess. 2010;14(17):1-153.
  45. Ochroch E, Mardini I, Gottschalk A. What is the role of NSAIDs in pre-emptive analgesia? Drugs. 2003;63(24):2709-2723.
  46. Ong KS, Seymour RA. An evidence-based update of the use of analgesics in dentistry. Periodontology. 2000;2008;46:143-164.
  47. Ramey DR, Walson DJ, Yu C, Bolognese JA, Curtis SP, Reicin AS. The incidence of upper gastrointestinal adverse events in clinical trials of etoricoxib vs. non-selective NSAIDs: an updated combined analysis. Curr Med Res Opin. 2005;21(5):715-722.
  48. Twersky RS, Philip BK. Handbook of Ambulatory Anesthesia. 2nd ed. 2008.
  49. Ryn J van, Kink-Eiband M, Kuritscb I, Feifel U, Hanft G, Wallenstein G, Trummlitz G, Pairet M. Meloxicam does not affect the antiplatelet effect of aspirin in bealt by male and female volunteers. J Clin Pharmacol. 2004;44(7):777-784.
  50. Seymour RA, Kelly PJ, Hawkesford JE. The efficacy of ketoprofen and paracetamol (acetaminophen) in postoperative pain after third molar surgery. Br Clin Pharmacol. 1996;41:581-585.
  51. Shah AA, Thjodleifsson B, Murray FE et al. Selective inhibition of COX-2 in humans is associated with less gastrointestinal injury: a comparison of nimesulide and naproxen. Gut. 2001;48:339-346.
  52. Silverstein FE, Faich, Goldstein JL et al Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. JAMA. 2000;284:1247-1255.
  53. Singh G, Lanes S, Triadafilopoulos G. Risk of serious upper gastrointestinal and cardiovascular thromboembolic complications with meloxicam. Am J Med. 2004;117(2):100-106.
  54. Singh G, Fort JG, Goldstein JL et al For the SUCCESS - I Investigators. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS - I Study. Am J Med. 2006;119:255-266.
  55. Tramer M, Williams J, Carroll D et al. Comparing analgesic efficacy of non-steroidal anti-inflammatory drugs given by different routes in acute and chronic pain: a qualitative systematic review. Acta Anaesthesiol Scand. 1998;42(1):71-79.
  56. Trelle S, Reicbenbacb S, Wandel S et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs network meta-analysis. BMJ. 2011;342:7086.
  57. Vane J. Towards a better aspirin. Nature. 1994;367:215-216.
  58. Vane JR, Botting RM, Vane JR, Botting RM. The history of anti-inflammatory drugs and their mechanism of action. In New Target in Inflammation. Inhibitors of COX-2 or adhesion molecules. Ed. Bazan N, Botting J, Vane J. Kluger Acad. Publishers; 1996:1-12.
  59. Warner TD, Giuliano F, Vojnovic I et al. Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase-2 are associated with human gastrointestinal toxicity: A full in vitro analysis. Proc Nat Acad Sci USA. 1999;96:7563-7568.
  60. Weber EWG, Slappendel R, Durieux ME, Dirksen R, Hvan der Heide, Spruit M. COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Europ J Anaesthiol. 2003;20:963-966.
  61. Winrelmayer WC, Walker SS, Mogun H, Solomon DH. Nonselective and cyclooxygenase-2 - selective NSAIDs and active kidney injure. Am J Med. 2008;121(12):1092-1098.
  62. White P. Multimodal analgesia: its role in preventing postoperative pain. Curr Opin Ivestig Grugs. 2008;9(1):76-82.
  63. Yagiela JA, Dowd FJ, Neidle EA, ed. Pharmacology and Therapeutics for Dentistry. 5th ed. Mosby, Inc.; 2004:331-364,565-572.

Close metadata

Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.